Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid
Giannis Mountzios, Evangelos Terpos, Konstantinos Syrigos, Christos Papadimitriou, Giorgos Papadopoulos, Aristotelis Bamias, Myron Mavrikakis, Meletios-Athanassios DimopoulosVolume:
155
Year:
2010
Language:
english
DOI:
10.1016/j.trsl.2010.01.002
File:
PDF, 125 KB
english, 2010